223 related articles for article (PubMed ID: 24482066)
1. Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial.
Lee BT; Gabardi S; Grafals M; Hofmann RM; Akalin E; Aljanabi A; Mandelbrot DA; Adey DB; Heher E; Fan PY; Conte S; Dyer-Ward C; Chandraker A
Clin J Am Soc Nephrol; 2014 Mar; 9(3):583-9. PubMed ID: 24482066
[TBL] [Abstract][Full Text] [Related]
2. Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial.
Knoll GA; Humar A; Fergusson D; Johnston O; House AA; Kim SJ; Ramsay T; Chassé M; Pang X; Zaltzman J; Cockfield S; Cantarovich M; Karpinski M; Lebel L; Gill JS
JAMA; 2014 Nov; 312(20):2106-14. PubMed ID: 25399012
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
4. Treatment of BK viremia after renal transplantation: are fluoroquinolones a false dawn?
Anwar S; Brennan DC
Clin J Am Soc Nephrol; 2014 Mar; 9(3):445-7. PubMed ID: 24482067
[No Abstract] [Full Text] [Related]
5. Quinolone prophylaxis for the prevention of BK virus infection in kidney transplantation: study protocol for a randomized controlled trial.
Humar A; Gill J; Johnston O; Fergusson D; House AA; Lebel L; Cockfield S; Kim SJ; Zaltzman J; Cantarovich M; Karpinski M; Ramsay T; Knoll GA
Trials; 2013 Jun; 14():185. PubMed ID: 23800312
[TBL] [Abstract][Full Text] [Related]
6. Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Schold JD; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Clin J Am Soc Nephrol; 2014 Mar; 9(3):553-61. PubMed ID: 24408118
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
Ji J; Feng S; Jiang Y; Wang W; Zhang X
Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
10. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
11. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.
Krisl JC; Taber DJ; Pilch N; Chavin K; Bratton C; Thomas B; McGillicuddy J; Baliga P
Clin J Am Soc Nephrol; 2012 Jun; 7(6):1003-9. PubMed ID: 22461534
[TBL] [Abstract][Full Text] [Related]
12. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
[TBL] [Abstract][Full Text] [Related]
13. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study.
Sood P; Senanayake S; Sujeet K; Medipalli R; Zhu YR; Johnson CP; Hariharan S
Transplantation; 2012 Oct; 94(8):814-21. PubMed ID: 23018881
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation.
Gabardi S; Waikar SS; Martin S; Roberts K; Chen J; Borgi L; Sheashaa H; Dyer C; Malek SK; Tullius SG; Vadivel N; Grafals M; Abdi R; Najafian N; Milford E; Chandraker A
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1298-304. PubMed ID: 20507960
[TBL] [Abstract][Full Text] [Related]
15. Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation.
Schaenman JM; Korin Y; Sidwell T; Kandarian F; Harre N; Gjertson D; Lum EL; Reddy U; Huang E; Pham PT; Bunnapradist S; Danovitch GM; Veale J; Gritsch HA; Reed EF
Transplantation; 2017 Jun; 101(6):1479-1487. PubMed ID: 27391197
[TBL] [Abstract][Full Text] [Related]
16. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
Jaw J; Hill P; Goodman D
Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
Vu D; Shah T; Ansari J; Naraghi R; Min D
Transplant Proc; 2015 Mar; 47(2):394-8. PubMed ID: 25769580
[TBL] [Abstract][Full Text] [Related]
18. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
20. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression.
Korneffel K; Gehring B; Rospert D; Rees M; Ortiz J
Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
